Search Results 11-20 of 17108 for nivolumab

  1. A Study Of The Effectiveness And Safety Of Nivolumab Compared To Bevacizumab And Of Nivolumab With Or Without Ipilimumab In Glioblastoma Patients - Mayo Clinic

    The purpose of the study is to compare the efficacy and safety of nivolumab administered alone versus bevacizumab in patients diagnosed with recurrent ...

  2. A Study To Test The Addition Of Nivolumab To Chemotherapy To Treat Soft Tissue Sarcoma - Mayo Clinic

    ... nivolumab and cabozantinib work in treating taxane pretreated patients with soft tissue sarcoma. Nivolumab works through the body's immune system to help ...

  3. Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous ...

  4. Comparison Of In-Home Versus In-Clinic Administration Of Subcutaneous Nivolumab Through Cancer CARE (Connected Access And Remote Expertise) Beyond Walls (CCBW) Program

    Studies have shown that cancer patients often feel more comfortable and secure being cared for in their own home environments. SC nivolumab in-home treatment ...

  5. Melanoma Relatlimab Nivolumab - Clinical Trials

    The purpose of this study is to determine whether Nivolumab in combination ... Nivolumab by itself in treating unresectable Melanoma or Melanoma that has spread ...

  6. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Participation eligibility. Participant eligibility ...

  7. A Study Of Nivolumab In Participants With Metastatic Or Unresectable Bladder Cancer - Mayo Clinic

    The purpose the study is to measure the effect of nivolumab (BMS-936558) in reducing tumor size in subjects with metastatic or unresectable bladder cancer.

  8. Nivolumab In Treating Patients With Relapsed Or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

    About this study. This phase II trial studies how well nivolumab works in treating patients with peripheral T-cell lymphoma that has come back after a ...

  9. Nivolumab And Brentuximab Vedotin In Treating Older Patients With Untreated Hodgkin Lymphoma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells. Biological therapies, such as brentuximab ...

  10. An Investigational Immuno-therapy Study Of Nivolumab, Compared To Placebo, In Patients With Bladder Or Upper Urinary Tract Cancer, Following Surgery To Remove The Cancer - Mayo Clinic

    An Investigational Immuno-therapy Study Of Nivolumab, Compared To Placebo, In Patients With Bladder Or Upper Urinary Tract Cancer, Following Surgery To Remove ...